Clinical Trial Update: Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating the efficacy and safety of fispemifene in hypogonadal men with chronic obstructive pulmonary disease on oral glucocorticoid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Hypogonadism

Drugs mentioned

• Fispemifene

Snippet

Sponsor: QuatRx Pharmaceuticals Company | Conditions: Hypogonadism, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED